Last C$0.52 CAD
Change Today +0.01 / 1.96%
Volume 1.0K
ATE On Other Exchanges
Symbol
Exchange
Venture
OTC US
Stuttgart
As of 9:30 AM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John Lawrence Wallace MSc, Ph.D., MBA

Founder, Chief Scientific Officer and Director, Antibe Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 36 board members in 2 different organizations across 3 different industries.

See Board Relationships
57C$295,111
As of Fiscal Year 2014

Background*

Dr. John Lawrence Wallace, M.Sc., Ph.D, MBA is the founder of Antibe Therapeutics, Inc. and serves as its Chief Scientific Officer. Dr. Wallace serves as a Professor of Pharmacology and Therapeutics, Physiology, Biophysics and Medicine at the University of Calgary, Canada. He served as the President of the Canadian Association of Gastroenterology from 2000 to 2002. He Co-Founded NicOx SA. Dr. Wallace served as the Chairman of Antibe Therapeutics, Inc until August 30, ...

Read Full Background

Corporate Headquarters*

15 Prince Arthur Avenue
Toronto, Ontario M5R 1B2

Canada

Phone: 905-726-0995
Fax: --

Board Members Memberships*

2009-Present
Founder, Chief Scientific Officer and Director

Education*

MBA
University of Birmingham
PhD
University of Toronto
MS
Queen's University
BS
Queen's University

Other Affiliations*

Annual Compensation*

SalaryC$261,625
Total Annual CompensationC$261,625

Stock Options*

Total Value of OptionsC$520,100
Total Number of Options1,190,000

Total Compensation*

Total Annual Cash CompensationC$261,625
Total Short Term CompensationC$261,625
Total Calculated CompensationC$295,111
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATE:CN C$0.52 CAD +0.01

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANTIBE THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.